ANDRE EYE DROPS
ANDRE EYE DROPS
Andre Laboratories Pvt.Ltd 495/7 8 GIDC Makarapura Vadodara 390010
Boric acid 1.25%+Chlorphen mal 0.01%+Sod chl 0.05%+Zinc sulp 0.012%+Chlorbutanol 0.035%+Chlorbutanol 0.035%+ Naphazoline hcl 0.056% all w/v eye drops,
|1.25%+0.01%+0.05%+0.012%||48.00||10ml Eye drops|
List of Related Indications:
List Of Drugs:
- Naphazoline ( * ) @ -Sympathomimetics Decongest/ Mydriatics
Indication Type Description:
Dosages/ Overdosage Etc
Pregnancy and lactation
Nasal decongestants include-
Arylalkalamine- Phenylpropanolamine, Pseudoephedrine, Phenylephrine, Epinephrine, Ephedrine, Desoxyephedrine, Irridazolines- Naphazoline, Oxymetazoline, Tetrahydrozoline, Xylomethazoline, Cycloalkyamine- Propylhexedrine
Hypersensitivity to any of the components
Special risk patients- use with caution in the presence of hypertension, diabetes, hyperthyroidism, cardiovascular abnormalities, arteriosclerosis Narrow angle glaucoma- ordrinarily any mydriatic is contraindicated in patients with glaucoma. However, when temporary pupil dilation may free adhesions or when vasoconstriction of intrinsic vessels may lower intraocular tension these advantages may temporarily outweigh danger from coincident pupil dilation.
Rebound congestion- may occur with frequent or extended use of ophthalmic vasoconstritors. this may be of importance when there is retinal deatchment or prior to cataract surgery. Rebound miosis have occured in older persons 1 day after receiving phenylephrine, reinstillation produced a reduction in mydriasis.
Pigment floaters- older individuals may develop transcient pigment floaters in the aqueous humor 30 to 45 minutes after instillation of phenylephrine
Anesthetics- discontinue prior to use of anesthetics which sensitize the myocardium to sympathomimetics (eg cyclopropane, halothane) Local anesthetics can increase absorption of topically applied drugs. Excercise caution when applying prior to use of phenylephrine Over use- may produce increased redness of the eye.
Pregnancy- safety for use during pregnancy is not established
Lactation- safety for use during breast feeding has not established, Use with caution when administerting to a nursing woman.
Children- safety and efficacy have not been not established
Dosages/ Overdosage Etc:
Adults and children over 12 years- 1 or 2 drops in each nostril as needed.
Pregnancy and lactation:
Safety for use during pregnancy is not established
Safety for use during breast feeding has not established, Use with caution when administerrting to a nursing woman.
Safety and efficacy have not been not established